Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

When to see a kidney specialist

Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

Most CKD is managed perfectly well in primary care. A specific minority benefits substantially from specialist input, and that group is well defined.

Late referral is associated with worse outcomes, unplanned dialysis starts and missed opportunities for transplant, so knowing the triggers is worth doing.

Related pages: Chronic kidney disease

The bottom line

What we know
  • eGFR persistently below 30 is a standard referral trigger.
  • A sustained decline of more than about 5 per year warrants assessment.
  • Heavy albuminuria, above 300 mg/g, is a trigger regardless of eGFR.
  • Persistent blood in the urine with protein needs specialist assessment.
  • Early referral improves preparation and access to transplantation.
What is still open
  • The optimal eGFR threshold for referral.
  • How much of the benefit of early referral is the referral itself.
  • How to deliver specialist input where nephrology access is limited.

The story, step by step

  1. 1. The thresholds ()
  2. 2. The other reasons ()
  3. 3. Why early matters ()
  4. 4. Making it useful ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 4

When referral is standard

Review of many studies

What happens

A short, specific list.

What the research shows

  • eGFR persistently below 30, which is stage 4 or worse.
  • A sustained decline of more than about 5 mL/min per year, or a drop of 25 percent or more from baseline with a change in stage.
  • Albumin-to-creatinine ratio above 300 mg/g, category A3, at any eGFR.
  • Persistent blood in the urine not explained by infection or stones, particularly with protein, which may indicate a glomerular disease needing biopsy.
  • CKD with high blood pressure that remains uncontrolled on four or more medicines.
  • Recurrent or extensive kidney stones, inherited kidney disease such as polycystic kidney disease, or an abnormality on imaging without an explanation.

Why it matters

These are specific enough to ask about directly. If any apply and no referral has been discussed, that is a reasonable question for the next appointment.

What's still uncertain

  • Whether thresholds should be age-adjusted.
  • How often these triggers are acted on in practice.

Read more

Next: The other reasons

Part 2 of 4

Where the cause is unclear

Review of many studies

What happens

Diagnosis as much as treatment.

What the research shows

  • CKD with no obvious cause, particularly in a younger person without diabetes or long-standing high blood pressure.
  • Persistent potassium abnormalities, whether high or low, that complicate treatment.
  • Suspected renal artery narrowing, suggested by a large fall in eGFR after starting an ACE inhibitor or by resistant hypertension.
  • Any suspicion of a treatable glomerular disease, where a biopsy and immune-suppressing treatment may change the course entirely.
  • Pregnancy with CKD, which needs joint management and adjustment of medicines, since ACE inhibitors and ARBs are stopped.
  • Acute kidney injury that has not recovered, which commonly leaves residual CKD and deserves follow-up rather than discharge.

Why it matters

The underlying question is whether anything specific can be done. That is the one a specialist is best placed to answer.

What's still uncertain

  • How often an unexplained cause is found on specialist assessment.
  • Who should receive a biopsy.

Read more

Next: Why early matters

Part 3 of 4

What late referral costs

Review of many studies

What happens

Preparation time.

What the research shows

  • Late referral is associated with higher mortality in the first year of dialysis and with more unplanned, emergency starts.
  • An arteriovenous fistula needs months to mature, so referral within weeks of needing dialysis forces a catheter, which carries higher infection risk.
  • A pre-emptive transplant, before dialysis begins, gives the best outcomes and requires a long workup, so it is only possible with early referral.
  • Early referral also allows anaemia, bone disease and acidosis to be managed before they cause harm.
  • And it allows an unhurried conversation about which treatment path fits the person's life, including conservative care.
  • Referral does not mean transfer. Most people continue with their usual clinician and see nephrology periodically.

Why it matters

Almost all the benefit of nephrology referral is about having time. That is the thing a late referral cannot provide.

What's still uncertain

  • How much of the outcome gap is referral timing versus underlying severity.
  • How to reduce unplanned dialysis starts.

Read more

Next: Making it useful

Part 4 of 4

What to bring and ask

Review of many studies

What happens

The trend, the list and the questions.

What the research shows

  • Bring the eGFR and urine albumin results over as many years as are available, not just the latest.
  • Bring a complete list of medicines and supplements, including anything bought over the counter.
  • Ask what is causing the kidney disease, and whether anything specific can be treated.
  • Ask what the likely trajectory is, and what would change it.
  • Ask whether all the available kidney-protective medicines are being used, and if not, why not.
  • Ask what the plan is if function continues to decline, and when that conversation should happen.
  • Ask whether a dietitian referral would help, since that is routinely available and routinely not offered.

Why it matters

A specialist appointment is short. Arriving with the trend and four specific questions changes what comes out of it.

What's still uncertain

  • How best to support shared decision-making in nephrology.
  • Whether structured question prompts improve outcomes.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.